<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CDHA CAAR &#187; acute myeloid leukemia</title>
	<atom:link href="http://www.ssc.wisc.edu/cdha/cinfo/?feed=rss2&#038;tag=acute-myeloid-leukemia" rel="self" type="application/rss+xml" />
	<link>http://www.ssc.wisc.edu/cdha/cinfo</link>
	<description>Current Awareness in Aging Research</description>
	<lastBuildDate>Thu, 02 May 2013 21:46:54 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.4</generator>
		<item>
		<title>CAAR &#8211; Lancet Oncology Article Abstract &#8211; April 8, 2013</title>
		<link>http://www.ssc.wisc.edu/cdha/cinfo/?p=4807</link>
		<comments>http://www.ssc.wisc.edu/cdha/cinfo/?p=4807#comments</comments>
		<pubDate>Mon, 08 Apr 2013 21:02:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Reports and Articles]]></category>
		<category><![CDATA[acute myeloid leukemia]]></category>

		<guid isPermaLink="false">http://www.ssc.wisc.edu/cdha/cinfo/?p=4807</guid>
		<description><![CDATA[&#8220;Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study,&#8221; by Jorge Cortes, Eric Feldman, Karen Yee, David Rizzieri, Anjali S. Advani, Anthony Charman, Richard Spruyt, Martin Toal, and Hagop Kantarjian (Vol. 14, No. 4, April 2013, p. 354-362). www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2813%2970037-8/abstract]]></description>
			<content:encoded><![CDATA[<p>&#8220;<strong>Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study</strong>,&#8221; by Jorge Cortes, Eric Feldman, Karen Yee, David Rizzieri, Anjali S. Advani, Anthony Charman, Richard Spruyt, Martin Toal, and Hagop Kantarjian (Vol. 14, No. 4, April 2013, p. 354-362).</p>
<p><a href=" http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2813%2970037-8/abstract"> <span style="font-size: 13px; line-height: 19px;"><a href="http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2813%2970037-8/abstract" class="autohyperlink" title="http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2813%2970037-8/abstract" target="_blank">www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2813%2970037-8/abstract</a></span></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.ssc.wisc.edu/cdha/cinfo/?feed=rss2&#038;p=4807</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CAAR &#8211; Lancet Oncology Article Abstract &#8211; October 30, 2012</title>
		<link>http://www.ssc.wisc.edu/cdha/cinfo/?p=3329</link>
		<comments>http://www.ssc.wisc.edu/cdha/cinfo/?p=3329#comments</comments>
		<pubDate>Tue, 30 Oct 2012 21:13:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Reports and Articles]]></category>
		<category><![CDATA[acute myeloid leukemia]]></category>

		<guid isPermaLink="false">http://www.ssc.wisc.edu/cdha/cinfo/?p=3329</guid>
		<description><![CDATA[Note: Lancet requires free registration prior to providing content. &#8220;Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study,&#8221; by Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Selina Luger, Parameswaran Venugopal, Lori Maness, Meir Wetzler, Steven Coutre, Wendy Stock, David Claxton, Stuart L Goldberg, Martha Arellano, Stephen A Strickland, [...]]]></description>
			<content:encoded><![CDATA[<p>Note: <em>Lancet</em> requires free registration prior to providing content. &#8220;<strong>Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study</strong>,&#8221; by Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Selina Luger, Parameswaran Venugopal, Lori Maness, Meir Wetzler, Steven Coutre, Wendy Stock, David Claxton, Stuart L Goldberg, Martha Arellano, Stephen A Strickland, Karen Seiter, Gary Schiller, Elias Jabbour, Judy Chiao, and William Plunkett (Vol. 13, No. 11, November 2012, p. 1096-1104).</p>
<p><a href="http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2812%2970436-9/abstract  ">www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2812%2970436-9/abstract</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.ssc.wisc.edu/cdha/cinfo/?feed=rss2&#038;p=3329</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>